These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16642499)

  • 1. Brain 1H magnetic resonance spectroscopic differences in myotonic dystrophy type 2 and type 1.
    Vielhaber S; Jakubiczka S; Gaul C; Schoenfeld MA; Debska-Vielhaber G; Zierz S; Heinze HJ; Niessen HG; Kaufmann J
    Muscle Nerve; 2006 Aug; 34(2):145-52. PubMed ID: 16642499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
    Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
    Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes.
    Valenzuela MJ; Sachdev PS; Wen W; Shnier R; Brodaty H; Gillies D
    Neuroimage; 2000 Dec; 12(6):747-56. PubMed ID: 11112406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
    Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
    J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
    Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2.
    Kornblum C; Reul J; Kress W; Grothe C; Amanatidis N; Klockgether T; Schröder R
    J Neurol; 2004 Jun; 251(6):710-4. PubMed ID: 15311347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manifestations of early brain recovery associated with abstinence from alcoholism.
    Bartsch AJ; Homola G; Biller A; Smith SM; Weijers HG; Wiesbeck GA; Jenkinson M; De Stefano N; Solymosi L; Bendszus M
    Brain; 2007 Jan; 130(Pt 1):36-47. PubMed ID: 17178742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study.
    Schneider-Gold C; Beer M; Köstler H; Buchner S; Sandstede J; Hahn D; Toyka KV
    Muscle Nerve; 2004 Nov; 30(5):636-44. PubMed ID: 15452841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
    Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
    Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylaspartate/creatine and choline/creatine ratios in the thalami, insular cortex and white matter as markers of hypertension and cognitive impairment in the elderly.
    Ben Salem D; Walker PM; Bejot Y; Aho SL; Tavernier B; Rouaud O; Ricolfi F; Brunotte F
    Hypertens Res; 2008 Oct; 31(10):1851-7. PubMed ID: 19015591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus.
    Filley CM; Kozora E; Brown MS; Miller DE; West SG; Arciniegas DB; Grimm A; Zhang L
    Cogn Behav Neurol; 2009 Mar; 22(1):38-44. PubMed ID: 19372769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.
    Sung YH; Cho SC; Hwang J; Kim SJ; Kim H; Bae S; Kim N; Chang KH; Daniels M; Renshaw PF; Lyoo IK
    Drug Alcohol Depend; 2007 Apr; 88(1):28-35. PubMed ID: 17084995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the metabolic profile in Type 2 diabetes mellitus and hypothyroidism through proton MR spectroscopy.
    Modi S; Bhattacharya M; Sekhri T; Rana P; Tripathi RP; Khushu S
    Magn Reson Imaging; 2008 Apr; 26(3):420-5. PubMed ID: 18164573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
    Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
    Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients.
    Oz G; Tkác I; Charnas LR; Choi IY; Bjoraker KJ; Shapiro EG; Gruetter R
    Neurology; 2005 Feb; 64(3):434-41. PubMed ID: 15699371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
    Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A
    Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation among subcortical white matter lesions, intelligence and CTG repeat expansion in classic myotonic dystrophy type 1.
    Kuo HC; Hsieh YC; Wang HM; Chuang WL; Huang CC
    Acta Neurol Scand; 2008 Feb; 117(2):101-7. PubMed ID: 18184345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2).
    Gaul C; Schmidt T; Windisch G; Wieser T; Müller T; Vielhaber S; Zierz S; Leplow B
    Neurology; 2006 Jul; 67(2):350-2. PubMed ID: 16864839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative proton magnetic resonance spectroscopic imaging: regional variations in the corpus callosum and cortical gray matter.
    Degaonkar MN; Pomper MG; Barker PB
    J Magn Reson Imaging; 2005 Aug; 22(2):175-9. PubMed ID: 16028259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.